TP53 and glioma: ADT has been shown to enhance the sensitivity of gliomas to radiotherapy both in vitro and in vivo (Hinrichs et al., 2018; Maletzki et al., 2017), particularly GBM cells with loss of p53 function (Hinrichs et al., 2018).